Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
Financial Statements
- Click here to download Quest Diagnostics, Inc.'s Income Statement
- Click here to download Quest Diagnostics, Inc.'s Balance Sheet
- Click here to download Quest Diagnostics, Inc.'s Statement of Cash Flows
Key Info
- Industry: Dental Laboratories
- Sector: Manufacturing
- CEO Name: Stephen Rusckowski
Key Statistics
- Stock Price: $131.27
- Dividend Yield: 1.9%
- Market Capitalization: $16,215,151,231
- Shares Outstanding: 122,674,771
- Number of Employees: 44,500
- Trailing 12-Month EPS: $16.63
- Trailing 12-Month DPS: $2.47
- Payout Ratio: 14.899999999999999%
Important Dates
- Next Earnings Date: 2022-04-21
- Next Ex-Dividend Date: 2022-01-18
Price Trends
- Current Stock Price: $131.27
- 52-week high: $174.16
- 52-week low: $114.55
- 200-day moving average: $148.48
- 50-day moving average: $136.56
Performance
- 1-Month Price Return: -2.1%
- 3-Month Price Return: -14.7%
- 6-Month Price Return: -11.0%
- 1-Year Price Return: 15.4%
- 2-Year Price Return: 22.3%
- 5-Year Price Return: 47.0%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast